Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification.

Brain tumor pathology - 1 Apr 2018

Akagi Yojiro, Yoshimoto Koji, Hata Nobuhiro, Kuga Daisuke, Hatae Ryusuke, Amemiya Takeo, Sangatsuda Yuhei, Suzuki Satoshi O, Iwaki Toru, Mizoguchi Masahiro, Iihara Koji

Abstract excerpt

In this study, we reclassified 400 consecutive glioma cases including pediatric cases, using the revised 2016 WHO classification with samples collected from the Kyushu University Brain Tumor Bank. The IDH1/2, H3F3A, key genetic markers in the 2016 classification, were analyzed using high-resolution melting, with DNA extracted from frozen tissues. The 1p/19q codeletions were evaluated using a microsatellite-based...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 10
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Loss of Heterozygosity

Share to Pathology, Molecular

Share to Survival

Share to World Health Organization

Source

Identifiers

PMID: 29569163
DOI: 10.1007/s10014-018-0313-4

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reclassification of 400 consecutive glioma cases based on the revised 2016WHO classification.PMID 29569163Read ↗

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.Semantic proximity Read ↗

Role of Molecular Pathology in the Treatment of Anaplastic Gliomas and Glioblastomas.Semantic proximity Read ↗

[Oligodendroglioma, IDH Mutation and 1p/19q Codeletion].Semantic proximity Read ↗

Practice of the New Integrated Molecular Diagnostics in Gliomas: Experiences and New Findings in a Single Chinese CenterSemantic proximity Read ↗

The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.Semantic proximity Read ↗

Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnostics.Semantic proximity Read ↗

[Evolution of Glioma Diagnosis: The WHO 2021 Classification and Beyond].Semantic proximity Read ↗

[How molecular biology can improve the clinical diagnosis of gliomas?]Semantic proximity Read ↗

[World Health Organization Classification of Central Nervous System Tumours, 5th Edition:Points of the Update and the Current Status].Semantic proximity Read ↗

The 2007 WHO classification of tumors of the central nervous system – what has changed?Semantic proximity Read ↗

Oligodendroglioma: pathology, molecular mechanisms and markersSemantic proximity Read ↗

Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.